Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
J. Am. Coll. Cardiol., Jul;60(5):434-80 (2012)
Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surge
Circulation., Jul;126(5):617-63 (2012)
Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation.
Hepatology., Jul;56(1):28-38 (2012)
Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients.
Hepatology., Jul;56(1):17-27 (2012)
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data.
Gut., Feb;60(2):255-60 (2011)
Use of an automated clinical management system improves outpatient immunosuppressive care following liver transplantation.
J Am Med Inform Assoc., 17(4):396-402 (2010 Jul-Aug)
Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation.
Virology., Jul;402(2):248-55 (2010)
Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1.
J. Gastroenterol. Hepatol., Mar;25(3):627-34 (2010)
Liver transplantation at the extremes of the body mass index.
Liver Transpl., Aug;15(8):968-77 (2009)
Should liver transplantation in patients with model for end-stage liver disease scores <or= 14 be avoided? A decision analysis approach.
Liver Transpl., Feb;15(2):242-54 (2009)
Investigation of putative multisubtype hepatitis C virus infections in vivo by heteroduplex mobility analysis of core/envelope subgenomes.
J. Virol., Aug;82(15):7524-32 (2008)
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
Gastroenterology., May;134(5):1342-51 (2008)
Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction.
Hepatology., Sep;46(3):649-57 (2007)
Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients.
Liver Transpl., Apr;13(4):516-22 (2007)
Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.
Gastroenterology., Apr;130(4):1107-16 (2006)
Identification of a specific gene expression pattern associated with HCV-induced pathogenesis in HCV- and HCV/HIV-infected individuals.
Virology., Jul;350(2):453-64 (2006)
Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients.
Gastroenterology., Jan;130(1):179-87 (2006)
Liver transplantation for erythropoietic protoporphyria liver disease.
Liver Transpl., Dec;11(12):1590-6 (2005)
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
Hepatology., Nov;42(5):1184-93 (2005)
Using root cause analysis to improve survival in a liver transplant program.
J. Surg. Res., Nov;129(1):6-16 (2005)